Position in NTRA
as of Jun 30, 2026
· filed Jul 31, 2026
Position Value
$1,429,455
+$349,710 QoQ
Shares Held
5,266
-2.5% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#403
of 844 holders
Holding Since
Dec 2023
8 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NTRA Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Aberdeen Group plc holds $1,035,545,424 across 24 Diagnostics & Research names. NTRA ranks #23 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | DHR |
Danaher Corp /De/
|
1,339,185 | $255,087,958 | |
| 2 | TMO |
Thermo Fisher Scientific Inc.
|
461,039 | $231,146,511 | |
| 3 | ICLR |
Icon PLC
|
394,362 | $68,504,622 | |
| 4 | WAT |
Waters Corp /De/
|
138,104 | $51,794,522 | |
| 5 | PSNL |
Personalis, Inc.
|
3,747,290 | $50,213,686 | |
| 6 | IDXX |
Idexx Laboratories Inc /De
|
91,286 | $48,056,601 | |
| 7 | IQV |
Iqvia Holdings Inc.
|
238,810 | $46,142,867 | |
| 8 | A |
Agilent Technologies, Inc.
|
288,030 | $38,259,024 |
All Filings in NTRA
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,429,455 | 5,266 | Shares | Defined | 2026-07-31 | |
| 2026-03-31 | $1,079,745 | 5,399 | Shares | Defined | 2026-04-29 | |
| 2025-12-31 | $232,754 | 1,016 | Shares | Defined | 2026-01-16 | |
| 2024-12-31 | $1,018,660 | 6,435 | Shares | Defined | 2025-01-24 | |
| 2024-09-30 | $4,351,338 | 34,276 | Shares | Defined | 2024-10-25 | |
| 2024-06-30 | $5,227,808 | 48,276 | Shares | Defined | 2024-08-09 | |
| 2024-03-31 | $7,809,403 | 85,386 | Shares | Defined | 2024-05-09 | |
| 2023-12-31 | $3,213,933 | 51,308 | Shares | Defined | 2024-01-31 | |
| No filing history on record for this holder in this stock. | ||||||